| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10856 | 2021 |
| Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 T Vos, SS Lim, C Abbafati, KM Abbas, M Abbasi, M Abbasifard, ... The lancet 396 (10258), 1204-1222, 2020 | 8233 | 2020 |
| Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ... The lancet 396 (10258), 1223-1249, 2020 | 6691* | 2020 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2077* | 2021 |
| Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic … H Wang, KM Abbas, M Abbasifard, M Abbasi-Kangevari, H Abbastabar, ... The Lancet 396 (10258), 1160-1203, 2020 | 1331 | 2020 |
| Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial M Martin, FA Holmes, B Ejlertsen, S Delaloge, B Moy, H Iwata, ... The lancet oncology 18 (12), 1688-1700, 2017 | 663 | 2017 |
| Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global … R Lozano, N Fullman, JE Mumford, M Knight, CM Barthelemy, C Abbafati, ... The Lancet 396 (10258), 1250-1284, 2020 | 575 | 2020 |
| 2, 3-Butanediol production by acetogenic bacteria, an alternative route to chemical synthesis, using industrial waste gas M Köpke, C Mihalcea, FM Liew, JH Tizard, MS Ali, JJ Conolly, B Al-Sinawi, ... Applied and environmental microbiology 77 (15), 5467-5475, 2011 | 500 | 2011 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 498* | 2021 |
| Discrimination through optimization: How Facebook's Ad delivery can lead to biased outcomes M Ali, P Sapiezynski, M Bogen, A Korolova, A Mislove, A Rieke Proceedings of the ACM on human-computer interaction 3 (CSCW), 1-30, 2019 | 455 | 2019 |
| What types of jobs do people with disabilities want? M Ali, L Schur, P Blanck Journal of occupational rehabilitation 21, 199-210, 2011 | 324 | 2011 |
| NAViGaTOR: network analysis, visualization and graphing Toronto KR Brown, D Otasek, M Ali, MJ McGuffin, W Xie, B Devani, IL Toch, ... Bioinformatics 25 (24), 3327-3329, 2009 | 289 | 2009 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 244 | 2022 |
| Potential for discrimination in online targeted advertising T Speicher, M Ali, G Venkatadri, FN Ribeiro, G Arvanitakis, F Benevenuto, ... Conference on fairness, accountability and transparency, 5-19, 2018 | 235 | 2018 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial J Frater, KJ Ewer, A Ogbe, M Pace, S Adele, E Adland, J Alagaratnam, ... The lancet HIV 8 (8), e474-e485, 2021 | 228 | 2021 |
| West Nile virus infection: MR imaging findings in the nervous system M Ali, Y Safriel, J Sohi, A Llave, S Weathers American Journal of Neuroradiology 26 (2), 289-297, 2005 | 188 | 2005 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 186 | 2022 |
| Redefining fatty liver disease: an international patient perspective G Shiha, M Korenjak, W Eskridge, T Casanovas, P Velez-Moller, ... The lancet Gastroenterology & hepatology 6 (1), 73-79, 2021 | 181 | 2021 |
| Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17 A Deshpande, MK Miller-Petrie, PA Lindstedt, MM Baumann, KB Johnson, ... The Lancet Global Health 8 (9), e1162-e1185, 2020 | 156 | 2020 |
| The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis EA Cromwell, CA Schmidt, KT Kwong, DM Pigott, D Mupfasoni, G Biswas, ... The Lancet Global Health 8 (9), e1186-e1194, 2020 | 141 | 2020 |
